StockWatch
·
NAVIN FLUORINE · Q2 FY-2027 · PREVIEW

Expect strong momentum continuation as debottlenecking ramps

After Q1's 44% revenue jump and doubled PAT, the Street watches for sustained growth momentum in Q2 as new capacity comes online. A DRDO partnership and captive power capex signal strategic depth, but execution on margin expansion will be the real test.

Q2 FY27 resultsNAVINFLUORNavin Fluorine International Limited-$24 Oct 2026 · 3 min read

The Setup

What to expect: Navin Fluorine enters Q2 FY27 with significant momentum. Q1 delivered ₹1,045.08 Cr consolidated revenue (44.1% YoY, 11.4% QoQ) and consolidated PAT of ₹243.31 Cr—more than doubling year-on-year. The Street will be watching for sustained mid-to-high 30s% growth in the new quarter as the Multi-Purpose Plant (MPP) debottlenecking capacity, commissioned in late September, begins to feed volume. Margins matter equally: Q1's PAT% expansion signals pricing/mix power, and Q2 estimates hinge on whether that sticks as new capacity ramps and input costs stabilize.

Expected consolidated revenue

~₹1,000–1,100 Cr

On-plan growth trajectory; Q1 grew 44% YoY to ₹1,045 Cr

PAT margin expectation

~23–24%

Q1 delivered strong PAT expansion; Street watches for sustenance vs input/FX headwinds

Capex deployment

₹90 Cr approved

Board approved in Q1; ₹3.63 Cr additional for captive power; medium-term capacity story intact

Volume/mix driver

MPP ramp-up

Debottlenecking live Sep 29; DRDO Sodium Borohydride partnership adds specialty segment opportunity

On Track to Guidance?

Full-year FY27 guidance has not been explicitly disclosed in the filings. However, the Q1 beat and operational momentum (MPP commissioning, capex authorization, DRDO partnership) suggest management is executing to an internal plan. The run-rate—₹1,000+ Cr quarterly revenue with 23%+ PAT margin—would imply an FY27 operating profit pool in the ₹950–1,000 Cr range, well ahead of FY26's levels. Street analysts expect FY27 EPS of ₹87.75, implying ~₹880–920 Cr consolidated PAT for the year; Q1's ₹243 Cr (annualizing to ~₹970 Cr) suggests the estimate may be conservative. The risk: if Q2 flattens sequentially or if the capex-driven growth story disappoints, the Street will need to reset.

What the Street Says

Since Last Quarter

Key filings & operational events (Q1 close to result date)

Sep 29, 2026

Event

MPP debottlenecking capacity commissioned

Significance

Volume growth catalyst; removes a previous constraint on specialty-chemical production

Sep 24, 2026

Event

Board meeting scheduled for Oct 30; trading window closed

Significance

Routine; result announcement date confirmed

Aug 05, 2026

Event

Q1 FY27 results announced; ₹90 Cr capex approved

Significance

Beat on revenue/PAT; medium-term expansion plan signals confidence

Jul 30, 2026

Event

DRDO partnership: Sodium Borohydride manufacturing agreement

Significance

Strategic; adds defence/chemistry segment; recurring potential under government contract

Jul 27, 2026

Event

₹3.63 Cr investment in Pro-Zeal captive power SPV

Significance

Operational efficiency play; reduces energy cost headwinds

Jul 06, 2026

Event

SBI Mutual Fund acquires 5% stake

Significance

Institutional participation; DII/MF holding now ~29% (stable)

What to Watch on Result Day

Three things that will move the stock
  • 1 · Margin print & guidance

    If PAT% stays above 23%, the Street resets FY27 estimates upward; if it dips below 22%, the narrative shifts to cost headwinds. Any FY27 or FY28 guidance will matter more than the number itself.

  • 2 · MPP ramp trajectory & new orders

    Disclosure of Q2 volume uptake from debottlenecking, and any update on DRDO supply milestones or other defence/specialty orders will signal how durable the growth is.

  • 3 · Capex spend & FY28 outlook

    An update on the ₹90 Cr capex deployment (timeline, ROI targets) and any new capex announcements will tell you whether management is confident in sustained demand or preparing for a cycle slow.

Navin Fluorine set up the print with a clean Q1 beat and two structural catalysts—new capacity online and a DRDO partnership—that address the old critique of being a cyclical commodity play. The Street has moved; consensus targets are now ₹9,635 high, and three-quarters of analysts are bulls. The risk for Q2 is straightforward: prove the margins and the capex ROI, or watch the stock re-rate. For long-only holders, a beat and a confident FY27 outlook likely trigger the next leg. For value traders, the stock is down 14% from ATH—a miss could accelerate that.

Informational and educational content only. Not investment advice.